{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:06:12Z","timestamp":1779318372559,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/iae.0b013e3182923463","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T13:47:08Z","timestamp":1367675228000},"page":"136-141","source":"Crossref","is-referenced-by-count":32,"title":["VITRECTOMY COMBINED WITH PERIOCULAR\/INTRAVITREAL INJECTION OF STEROIDS FOR RHEGMATOGENOUS RETINAL DETACHMENT ASSOCIATED WITH CHOROIDAL DETACHMENT"],"prefix":"10.1097","volume":"34","author":[{"given":"Yong","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuncao","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqiao","family":"Zu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1972.01000030483003","article-title":"Combined choroidal and retinal detachment.","volume":"88","author":"Gottlieb","year":"1972","journal-title":"Arch Ophthalmol"},{"key":"R2-19-20210130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/archopht.1974.03900060264003","article-title":". Choroidal detachment associated with primary retinal detachment.","volume":"91","author":"Seelenfreund","year":"1974","journal-title":"Arch Ophthalmol"},{"key":"R3-19-20210130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00006982-199414040-00008","article-title":". Scleral buckling for retinal detachment. Predictors for anatomic failure.","volume":"14","author":"Sharma","year":"1994","journal-title":"Retina"},{"key":"R4-19-20210130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3928\/1542-8877-19970401-05","article-title":"Pars plana vitrectomy in the treatment of combined rhegmatogenous retinal detachment and choroidal detachment in aphakic or pseudophakic patients.","volume":"28","author":"Yang","year":"1997","journal-title":"Ophthalmic Surg Lasers"},{"key":"R5-19-20210130","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/S0161-6420(98)91230-1","article-title":"Primary vitrectomy for rhegmatogenous retinal detachment associated with choroidal detachment.","volume":"105","author":"Sharma","year":"1998","journal-title":"Ophthalmology"},{"key":"R6-19-20210130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00006982-200502000-00006","article-title":". Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study.","volume":"25","author":"Sharma","year":"2005","journal-title":"Retina"},{"key":"R7-19-20210130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s004170100345","article-title":"Primary vitrectomy for the management of rhegmatogenous retinal detachment associated with choroidal detachment.","volume":"239","author":"Ghoraba","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R8-19-20210130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73759-6","article-title":"The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.","volume":"120","author":"Helm","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R9-19-20210130","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/bjo.87.8.968","article-title":". Trans-Tenons retrobulbar triamcinolone infusion for the treatment of uveitis.","volume":"87","author":"Okada","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R10-19-20210130","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","article-title":"Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.","volume":"84","author":"Jonas","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R11-19-20210130","first-page":"653","article-title":". Statistical study of aqueous flare in rhegmatogenous retinal detachment in Japanese.","volume":"98","author":"Watanabe","year":"1994","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"R12-19-20210130","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/archopht.1984.01040031488029","article-title":"Serum contains chemoattractants for human retinal pigment epithelial cells.","volume":"102","author":"Campochiaro","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R13-19-20210130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjo.35.11.730","article-title":"Effect of cortisone on the permeability of the blood-aqueous barrier to fluorescein.","volume":"35","author":"Cook","year":"1951","journal-title":"Br J Ophthalmol"},{"key":"R14-19-20210130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006982-199701000-00009","article-title":"Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy.","volume":"17","author":"Rubsamen","year":"1997","journal-title":"Retina"},{"key":"R15-19-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archopht.1994.01090130127029","article-title":". Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy.","volume":"112","author":"Ando","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R16-19-20210130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archopht.1965.00970040794010","article-title":". Scleral buckling procedures. 8. Preoperative complications.","volume":"74","author":"Brockhurst","year":"1965","journal-title":"Arch Ophthalmol"},{"key":"R17-19-20210130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archopht.1974.01010010155016","article-title":"Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis.","volume":"92","author":"Graham","year":"1974","journal-title":"Arch Ophthalmol"},{"key":"R18-19-20210130","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0002-9394(14)75196-7","article-title":"Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.","volume":"90","author":"Tano","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"R19-19-20210130","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-9394(14)76037-4","article-title":". The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.","volume":"99","author":"Chandler","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"R20-19-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","article-title":". The clearance of intravitreal triamcinolone acetonide.","volume":"93","author":"Schindler","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"R21-19-20210130","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archopht.1985.01050100143037","article-title":". Clearance of triamcinolone from vitreous.","volume":"103","author":"Scholes","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R22-19-20210130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":". Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"R23-19-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.116.1.69","article-title":". An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.","volume":"116","author":"Yang","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"R24-19-20210130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)75004-4","article-title":"The pathophysiology of proliferative vitreoretinopathy in its management.","volume":"100","author":"Ryan","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"R25-19-20210130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF02144131","article-title":"The use of silicone oil following failed vitrectomy for retinal detachment with advanced proliferative vitreoretinopathy.","volume":"224","author":"McCuen","year":"1986","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R26-19-20210130","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3928\/1542-8877-20001101-07","article-title":". Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.","volume":"31","author":"Kivilcim","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"R27-19-20210130","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ophtha.2008.05.016","article-title":". Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.","volume":"115","author":"Ahmadieh","year":"2008","journal-title":"Ophthalmology"},{"key":"R28-19-20210130","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.86.12.1450-a","article-title":"Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil.","volume":"86","author":"Jonas","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R29-19-20210130","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archopht.122.10.1571-b","article-title":"Rinsing of the cannula prior to intravitreal injection.","volume":"122","author":"Degenring","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R30-19-20210130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":". Intravitreal triamcinolone acetonide and intraocular pressure.","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R31-19-20210130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0008-4182(05)80052-3","article-title":". Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy.","volume":"40","author":"Munir","year":"2005","journal-title":"Can J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e3182923463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T02:25:13Z","timestamp":1644978313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201401000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3182923463","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}